Zimmer Biomet Announces Potential Job Cuts in Swiss Plant

Zimmer Biomet, a US-based medtech company, has signaled potential job reductions at its Winterthur facility, where up to 580 of the current 730 positions could be eliminated in a restructuring effort. The announcement follows the company’s acquisition of Centerpulse in 2003, which originally operated as a Sulzer subsidiary specializing in prosthetic joints, including artificial knees and hips. The Swiss plant, established in 2003, remains a key operational hub for Zimmer Biomet, known for its long-standing expertise in orthopedic implants.